Indeed, activation of NF-kB - the major downstream mediator of RANK signaling - has been associated with cell survival, proliferation, and invasion, as well as resistance to anti-ErbB2 agents in ErbB2-positive breast cancers [91, 99, 100]. This evidence concerns the gene ERBB2 and breast cancer.